Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial Patients with breast cancer should be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results